A rare cause of neonatal hypercalcemia: Neonatal severe primary hyperparathyroidism: A case report and review of the literature
- PMID: 31931451
- PMCID: PMC6957862
- DOI: 10.1016/j.ijscr.2019.12.024
A rare cause of neonatal hypercalcemia: Neonatal severe primary hyperparathyroidism: A case report and review of the literature
Abstract
Introduction: Neonatal severe primary hyperthyroidism is an extremely rare disorder that occurs in the first six months of life. Early recognition and prompt surgical intervention are of vital importance for survival and to avoid neurological sequel. Hypotonia, lethargy, respiratory distress, and growth and developmental delay occur in association with elevated serum parathormone levels and hypercalcemia (Gannon et al., 2014). Definitive therapy involves total parathyroidectomy.
Case presentation: We are presenting a patient with Neonatal severe primary hyperparathyroidism, who successfully underwent total parathyroidectomy. The patient had been followed up with medical therapy until he was seven months old, with no adequate clinical response to medical therapy. Parathormone levels rapidly declined following total parathyroidectomy, and the parathormone level fell to zero after removal of the ectopic tissue with a second surgery, and the patient was discharged with full recovery.
Discussion: Sestamibi scintigraphy might not always show an ectopic parathyroid gland. In such conditions, confirmation of parathyroid glands excised with total parathyroidectomy by frozen biopsy is not sufficient to terminate surgery. Intraoperative parathormone monitoring is particularly important at this point. Persistently elevated parathormone levels should suggest a remnant parathyroid tissue at the surgical site or an ectopic parathyroid gland that needs to be excised.
Conclusion: Neonatal severe primary hyperparathyroidism is a life-threatening condition. Early surgery is life-saving in cases in whom medical therapy fails to control the disease.
Keywords: CASR gene mutation; Hypercalcemia of the newborn; Intraoperative PTH monitoring; Neonatal hyperparathyroidism; Sestamibi scan.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest No potential conflicts of interest.
Figures





Similar articles
-
Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR: A rare cause of life-threatening hypercalcemia.Eur J Med Genet. 2016 Apr;59(4):227-31. doi: 10.1016/j.ejmg.2016.02.001. Epub 2016 Feb 6. Eur J Med Genet. 2016. PMID: 26855056 Review.
-
Case report: lady with bone pains for 5 years-parathyroid carcinoma.BMC Res Notes. 2018 Aug 29;11(1):617. doi: 10.1186/s13104-018-3711-0. BMC Res Notes. 2018. PMID: 30157930 Free PMC article.
-
[Surgical therapy concept in primary hyperparathyroidism].Schweiz Med Wochenschr Suppl. 2000;116:62S-65S. Schweiz Med Wochenschr Suppl. 2000. PMID: 10780075 German.
-
Neonatal severe hyperparathyroidism secondary to a novel homozygous CASR gene mutation.Clin Cases Miner Bone Metab. 2017 Sep-Dec;14(3):354-358. doi: 10.11138/ccmbm/2017.14.3.354. Epub 2017 Dec 27. Clin Cases Miner Bone Metab. 2017. PMID: 29354167 Free PMC article.
-
Severe primary hyperparathyroidism in a neonate having a parent with hypercalcemia: treatment by total parathyroidectomy and simultaneous heterotopic autotransplantation.Surgery. 1990 Nov;108(5):933-8. Surgery. 1990. PMID: 2237775 Review.
Cited by
-
Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience.Front Pediatr. 2022 Aug 24;10:926986. doi: 10.3389/fped.2022.926986. eCollection 2022. Front Pediatr. 2022. PMID: 36090548 Free PMC article.
-
Pediatric Neuroendocrine Neoplasia of the Parathyroid Glands: Delving into Primary Hyperparathyroidism.Biomedicines. 2023 Oct 17;11(10):2810. doi: 10.3390/biomedicines11102810. Biomedicines. 2023. PMID: 37893182 Free PMC article. Review.
-
Ten-year follow-up report and neurologic sequelae in a case of neonatal severe primary hyperparathyroidism.Clin Case Rep. 2023 Jul 23;11(7):e7626. doi: 10.1002/ccr3.7626. eCollection 2023 Jul. Clin Case Rep. 2023. PMID: 37492070 Free PMC article.
-
The role of calcium-sensing receptor signaling in regulating transepithelial calcium transport.Exp Biol Med (Maywood). 2021 Nov;246(22):2407-2419. doi: 10.1177/15353702211010415. Epub 2021 Apr 29. Exp Biol Med (Maywood). 2021. PMID: 33926258 Free PMC article. Review.
-
A Case of Neonatal Severe Hyperparathyroidism: Challenges in Management.Indian J Pediatr. 2022 Oct;89(10):1025-1027. doi: 10.1007/s12098-022-04169-1. Epub 2022 Apr 5. Indian J Pediatr. 2022. PMID: 35380381 Free PMC article.
References
-
- Agha R.A., Borrelli M.R., Farwana R., Koshy K., Fowler A., Orgill D.P., For the SCARE Group The SCARE 2018 statement: updating consensus surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2018;60:132–136. - PubMed
-
- Hendy G.N., Guarnieri V., Canaff L. Calcium-sensing receptor and associated diseases. Progr. Mol. Biol. Transl. Sci. 2009;89C:31–95. - PubMed
-
- Tfelt-Hansen J., Brown E.M. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit. Rev. Clin. Lab. Sci. 2005;42:35–70. - PubMed
-
- Hendy G.N., Cole David E.C. Genetic defects associated with familial and sporadic hyperparathyroidism. Front. Horm. Res. 2013;41:149–165. Epub 2013 Mar 19. - PubMed
Publication types
LinkOut - more resources
Full Text Sources